Recent News

102 News Items found
John Mendelsohn
Remembering John Mendelsohn, a Pioneer of Targeted Therapy for Cancer
The scientific world lost one of its greats this week. Here, we reflect on his influence.
Top 10 Stories of 2018, Cancer Research Edition
Take a look back at some of the year’s biggest news in cancer research.
an illustration of a cigarette burning and smoke entering lungs
How Do Cigarettes Cause Cancer?
Everyone knows that cigarettes cause cancer. But what do we know about how they do it?
ASH meeting signage
Advances in Myeloma, Lymphoma, and Bone Marrow Transplant Announced at the 2018 ASH Meeting
Learn more about the work of MSK researchers being presented at the 2018 meeting of the American Society of Hematology.
Jonathan Peled speaks during a press conference
Gut Microbes May Protect People Having Bone Marrow Transplants
For the first time, researchers have found an association between the makeup of the microorganisms in the body before a bone marrow transplant and a patient’s survival afterward.
In the News
James Allison
Former MSK Immunologist James Allison Wins Nobel Prize in Medicine
Dr. Allison is being honored for discovering how to take the brakes off cancer-fighting immune cells.
In the Lab
kratom leaves and pill
Kratom: What Research Tells Us about This Controversial Supplement for Pain Relief
Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.
MSK cell manufacturing specialist Xiuyan Wang
Meet the Scientists Who Engineer CAR T Cells, a Type of "Living" Immunotherapy
An immunotherapy called CAR T is transforming the treatment of certain cancers. These are the people who make it possible.
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity
A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
Leukemia cells
Findings from Two Patients Shed New Light on Drug Resistance in AML
A team at MSK has discovered a previously unknown type of resistance to a new leukemia drug.